Gif-sur-Yvette, France

Beng Poon Teng


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Beng Poon Teng

Introduction

Beng Poon Teng is a notable inventor based in Gif-sur-Yvette, France. He has made significant contributions to the field of biotechnology, particularly in the development of plant-derived proteins with potential therapeutic applications. With a total of 4 patents, his work focuses on addressing critical health issues, including cancer treatment.

Latest Patents

Among his latest patents is Heterocarpine, a plant-derived protein recognized for its anti-cancer properties. This invention includes a method of treating cancer that relies on the growth factor GHRH in warm-blooded animals. Additionally, he has developed an isolated protein extended for Heterocarpine, which acts as a human GHRH-binding protein. This protein, derived from plants, can be utilized to create medicaments aimed at counteracting the effects of GHRH and treating proliferative diseases such as cancer, acromegaly, and diabetic nephropathies and retinopathies.

Career Highlights

Beng Poon Teng is associated with the Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS), where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

He collaborates with esteemed colleagues, including Eric Ferrandis and Christine Sohier, who contribute to his research endeavors and the development of innovative solutions in the field.

Conclusion

Beng Poon Teng's contributions to biotechnology and his innovative patents highlight his commitment to improving health outcomes through scientific research. His work exemplifies the importance of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…